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Peptide-DNA complexThe role of cell surface and exogenous glycosaminoglycans (GAGs) in DNA delivery by cationic peptides is
controlled to a large extent by the peptide chemistry and the nature of its complex with DNA. We have
previously shown that complexes formed by arginine homopeptides with DNA adopt a GAG-independent
cellular internalization mechanism and show enhanced gene delivery in presence of exogenous GAGs. In
contrast, lysine complexes gain cellular entry primarily by a GAG-dependent pathway and are destabilized
by exogenous GAGs. The aim of the current study was to elucidate the factors governing the role of cell
surface and soluble glycosaminoglycans in DNA delivery by sequences of arginine-rich peptides with altered
arginine distributions (compared to homopeptide). Using peptides with clustered arginines which constitute
known heparin-binding motifs and a control peptide with arginines alternating with alanines, we show that
complexes formed by these peptides do not require cell surface GAGs for cellular uptake and DNA delivery.
However, the charge distribution and the spacing of arginine residues affects DNA delivery efﬁciency of
these peptides in presence of soluble GAGs, since these peptides show only a marginal increase in transfection
in presence of exogenous GAGs unlike that observed with arginine homopeptides. Our results indicate that
presence of arginine by itself drives these peptides to a cell surface GAG-independent route of entry to efﬁciently
deliver functional DNA into cells in vitro. However, the inherent stability of the complexes differ when the
distribution of arginines in the peptides is altered, thereby modulating its interaction with exogenous GAGs.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Glycosaminoglycans (GAGs) on the plasma membrane are the
major contributors of the negative charge on the cell surface. These
molecules have been proposed to inﬂuence the delivery of cationic
gene delivery agents in numerous ways [1]. GAGs can electrostatically
bind to cationic gene delivery vectors like lipoplexes, polyplexes and
cell penetrating peptides and act as initial attachment sites or receptors
to enhance their gene delivery efﬁciency [1,2]. Alternatively, strong
binding to the cell surface GAGsmay destabilize the cationic gene deliv-
ery vectors [3]. Arginine-containing cell penetrating peptides like the
naturally occurring HIV-TAT, Antp, penetratin as well as synthetic argi-
nine homopeptides have been found to interact with cell surface GAGs
with high afﬁnity, whichpromotes their cellular uptake [4–9]. However,se hamster ovary; PBS, phos-
EtBr, ethidium bromide; AFM,
roitin sulfate; C6S, chondroitin
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ib.in (M. Ganguli).
l rights reserved.when cell penetratingpeptides are attached to a cargo either covalently or
electrostatically, the interaction of the resulting complexes with the cell
surface GAGs may not be similar to that of the free peptides [10–12], as
it can be affected by the net charge on the complex, the orientation of
the peptides and the availability of free peptides in the complex.
Arginine basedpeptides have beenwidely described in the literature
as efﬁcient molecular transporters for a variety of cargos, with the po-
tential to transfect a wide range of cells [13–15]. In a previous report,
we have demonstrated that oligoarginine, speciﬁcally R16, can enter
cells independent of the cell surface GAGs, and mediate efﬁcient cargo
activity [16]. Although the free peptide exhibits direct translocation
for entry, the polyplexes formed by R16 complexed with plasmid DNA
shows uptake by endocytosis. Both these pathways are also operational
in a GAG-deﬁcient cell line [17], supporting the evidence that cell sur-
face GAGs are not essential for cellular entry of arginine homopeptides.
Other recent reports have also supported this observation in case of
both the free and cargo-conjugated arginine-rich peptide [12,18].
Subrizi et al. have also demonstrated that the cationic charge on the
peptides, and not its sequence, determine the efﬁciency of cellular
entry [18]. However, the guanidino group in arginine side chains can in-
teract electrostatically as well as through hydrogen bonds with the sul-
fate groups on GAGs [19]. This property is exploited by the R16-DNA
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enously) on their surface. The presence of exogenous GAGs protects the
complexes leading to minimal destabilization during cellular entry and
increased cellular uptake and transfection efﬁciency [16].
The goal in this study was to check whether the sequence of the ar-
ginine peptides is important in determining the interaction of the
peptide-DNA complexes with cell surface and soluble GAGs. For this,
we designed peptides containing GAG-binding motifs identiﬁed by
Cardin andWeintraub [20]. Thesemotifs contain clusters of basic charge
arranged in patterns of XBBXBX or XBBBXXBX, where B represents a
positively charged residue, usually arginine or lysine, and X represents
an uncharged or hydrophobic amino acid [20,21]. Control arginine-
rich peptide sequences were also chosen which do not contain any
GAG-binding motif. This would help us determine whether the charge
distribution in the arginine-rich peptides, as listed in Table 1 (with
few lysine counterparts for comparison), can modulate their interaction
with GAGs and whether the presence of the motifs is favoring a GAG-
dependent entry pathway. Our results demonstrate that the presence of
arginines is the lone prerequisite for utilization of a GAG-independent
route of entry into cells by different arginine-rich peptide-DNA com-
plexes. However, the effect of soluble GAGs on the DNA delivery efﬁcien-
cy of the peptides seems to strongly depend on the charge distribution
and spacing of the arginine residues. These results would help in better
designing of arginine-rich peptides for delivery in multiple cell types.
2. Materials and methods
2.1. Materials
The peptides used in this study were custom synthesized by
G.L.Biochem (Shanghai) Ltd (>95% purity). The plasmids pEGFP-C1, 4.7
Kb (Clontech) and pMIR-REPORTTM Luciferase, 6.47 Kb (Ambion) were
ampliﬁed in E.coli DH5-α and puriﬁed using GenElute HP Endotoxin-
Free Plasmid MaxiPrep Kit (Sigma). All other chemicals and cell culture
media were procured from Sigma, unless mentioned otherwise.
2.2. Cell culture
Parental Chinese Hamster Ovary cells (CHO-K1)were obtained from
National Centre for Cell Science Cell Repository, India. The glycosamino-
glycan mutant cell lines pgsA-745 and pgsD-677 were obtained from
American Type Culture Collection. CHO-K1 and pgsA-745 cell lines
were maintained in Ham's F12K medium, and pgsD-677 in Ham's F12
medium. All media were supplemented with 10% (v/v) fetal bovine
serum (Life Technologies, U.S.A) and cells were kept in a humidiﬁed
5% CO2, 37 °C incubator.
2.3. Ethidium bromide exclusion assay
20 μl of DNA solution (20 ng/μl) was added to black 96 well plates
(Nunc) followed by addition of 20 μl of peptide dilutions at increasingTable 1
List of peptides used in this study.
Sequences are based on arrays of known heparin binding motifs where B represents
basic residue and X represents hydropathic residue.
GAG binding motif Peptide
sequence
No. of
residues
No. of positive
charges
Acronym
XBBBXXBX (ARRRAARA)4 32 16 32 A-R
(AKKKAAKA)4 32 16 32 A-K
(ARRRAARA)3 24 12 24 A-R
(AKKKAAKA)3 24 12 24 A-K
XBBXBX (ARRARA)5 30 15 30 A-R
(AKKAKA)5 30 15 30 A-K
- (RA)16 32 16 32 RAcharge ratios. After 10 min, 10 μl EtBr (4.22 ng/μl) was added and fur-
ther incubated for 5 min in the dark. Fluorescence intensity was mea-
sured in DTX 880 Multimode detector (Beckman Coulter) using 535
and 595 excitation and emission ﬁlters respectively. The ﬂuorescence
of DNA with EtBr was taken as the maximum, i.e. 100% and the rela-
tive percentage decrease in ﬂuorescence signal on addition of increas-
ing amounts of peptide was calculated and plotted as percentage of
maximum vs. charge ratio.
2.4. Transfection and luciferase gene expression assay
Polyplexes were prepared, as described previously [16], at different
charge ratios with ﬁnal DNA concentration of 20 ng/μl (pMIR-ReportTM
Luciferase) and incubated for one hour at room temperature. Indicated
amounts of GAGs, expressed as GAG:peptide w/w, were added to the
complexes after 30 min of incubation and kept for further 30 min.
100 μl of polyplex (2 μg DNA/well) was added to cells in 24-well plates
at 70% conﬂuency in serum free media (OptiMEM, Invitrogen). After
5 hours of incubation at 37 °C, cells were replenished with 500 μl com-
plete growthmedium. After 24 hours of transfection, luciferase expres-
sion was measured as previously described [16].
For enzymatic removal of cell surface GAGs, CHO-K1 cells were
seeded in 24-well plates and treated with GAG lyases after 24 h.
Cells were treated with either chondroitinase ABC (250 milliunits)
or heparinase III (2 mIU) in 300 μl of digestion buffer (PBS containing
0.1% BSA, 0.2% gelatin and 0.1% glucose) [4] for 1 h at 37 °C. Cells
were washed extensively with PBS and serum free media before
transfection was carried out as detailed above.
2.5. Flow cytometry analysis
Cells were grown for 24 h in 24-well plates and ﬂuorescently
labeled polyplexes at different charge ratios, where DNA was labeled
with FITC as described previously [16], were added to cells in serum
free media as detailed in the transfection protocol. After 4 h of incu-
bation at 37 °C, cells were washed twice with ice-cold PBS containing
1 mg/ml heparin, and with 0.4% trypan blue in PBS to remove any
extracellular ﬂuorescence. Cells were collected by trypsinization,
resuspended in PBS and placed on ice. Flow Cytometry measure-
ments were carried out on Guava® EasyCyteTM System (Guava Tech-
nologies) using CytoSoftTM software. 10,000 live cells were used for
each analysis.
2.6. Stability of polyplexes in presence of GAGs
The polyplexes formed at charge ratio Z (+/−) of 10 (20 μl
containing 200 ng DNA) were treated with increasing amounts of
GAGs (heparin, heparan sulfate, chondroitin 6-sulfate) and incubated
for 30 min before analysis by agarose gel electrophoresis. The amount
of the DNA released from the polyplexes was compared with that of
the native uncomplexed DNA.
For ethidium bromide (EtBr) intercalation assay, GAGs, at increas-
ing amounts, were added to black 96 well plates (Nunc), followed by
addition of 20 μl of polyplex (at Z(+/−) of 10.0) and 10 μl EtBr
(4.22 ng/μl) and incubated for 5 min at room temperature in the
dark. Fluorescence intensity was measured as mentioned in 2.3. The
ﬂuorescence of DNA with EtBr was taken as the maximum, i.e. 100%
and the relative percentage increase in ﬂuorescence signal was calcu-
lated at increasing concentration of GAGs.
2.7. DNaseI assay
DNaseI assay was performed as previously described [16]. Brieﬂy,
the polyplexes at Z(+/−) 10 were incubated with different concen-
trations of GAGs for 30 min at room temperature. The complexes
were then treated with DNaseI (1U) for 30 min at 37 °C. DNaseI
Fig. 1. Peptides containing GAG binding motif(s) can efﬁciently condense plasmid
DNA. Comparison of DNA condensation ability of arginine (A) and lysine (B) based
peptides by ethidium bromide exclusion assay. The ﬂuorescence of EtBr is inhibited
as it is excluded from the plasmid with increasing concentrations of peptide depicted
as charge ratio Z(+/−). Fluorescence of free plasmid complexed to EtBr is taken as
100%. Values are plotted as percentage of maximum±S.D.
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protected DNA from the polyplex, heparin (5 μg) was added to the
above reaction mixture and was further incubated for 30 min at
room temperature. The integrity and amount of DNA protected was
analyzed by electrophoresis on 1% agarose gel.
2.8. Atomic force microscopy (AFM)
The polyplexes at Z(+/−) 10 with or without GAGs were imaged
by depositing 2 μl of the polyplex solution on freshly cleaved mica
and drying it in air. Appropriate controls of GAGs were also similarly
imaged. Imaging was carried out with 5500 scanning probe micro-
scope (Agilent Technologies, Inc., AZ) using PicoView software. Im-
ages were obtained in AAC mode in air with 225 μm long silicon
cantilevers (Agilent Technologies, Inc.) that have resonance frequen-
cy of around 75 kHz and force constant of 2.8 N/m. Scan speed used
was 1 line/s. Minimum image processing (ﬁrst order ﬂattening and
brightness contrast) was employed. Image analysis was performed
using PicoImage software.
2.9. Dynamic light scattering (DLS)
The hydrodynamic diameters of the polyplexes at Z(+/−) 10.0,
with and without exogenous CS, were measured using Zetasizer
Nano-ZS (Malvern Instruments), at a ﬁxed angle of 90° at 25 °C. At
least 3 readings were recorded for each sample (each reading had
15 sub measurements).
3. Results
Our objective in this work was to examine whether the role of cell
surface and exogenous GAGs in mediating cellular entry and nucleic
acid delivery by arginine-rich peptides was affected by modiﬁcations
in the peptide sequence. The following peptides were chosen for this
study:
(a) 32A-R and 24A-R peptide containing clustered arginine resi-
dues arranged such that they form a consensus heparin bind-
ing sequence XBBBXXBX where X is alanine and B is arginine.
The corresponding lysine rich peptides have also been studied
in selected cases where arginine is replaced by lysine in the
above mentioned series (32A-K and 24A-K). Another peptide
with heparin binding motif having the general sequence of
XBBXBX (X=alanine and B=arginine) has also been used
for validation in selected cases (30A-R).
(b) Arginine-rich peptide containing alternating arginine and ala-
nine residues but no binding motif (32RA), which has similar
length and charges as the 32A-R.
All the peptides are listed in Table 1.
3.1. Peptides with GAG-binding motif can effectively condense plasmid
DNA and show DNA delivery
A critical prerequisite for efﬁcient DNA delivery is the ability of the
carrier to effectively condense the DNA in order to protect it from the
extracellular environment and facilitate cellular entry. Therefore, using
an ethidium bromide (EtBr) exclusion assay, we determined whether
all the peptides used in this study were able to condense DNA efﬁcient-
ly. As shown in Fig. 1, all the peptides showed complete condensation of
plasmid DNA between charge ratios, Z(+/−) of 1.5 – 2.5. In general, the
arginine-rich peptides (Fig. 1A), except for 32A-R, condensed DNA at
lower charge ratios than their lysine-rich counterparts (Fig. 1B), in
concordance with our earlier results for different lengths of arginine
and lysine homopeptides [22]. In addition, a peptide containing same
number of arginines but alternating arginine and alanine residues
(32RA) could completely condense the DNA only at a much highercharge ratio of 5.0 (Fig. 1A). The morphology of the peptide-DNA com-
plexes (polyplexes) at a charge ratio of 10.0 was studied using Atomic
Force Microscopy (Fig. 2A). The arginine-rich polyplexes showed
mostly spherical structures at Z(+/−) 10.0, whereas the lysine-rich
polyplexes showed both spherical and rod shaped structures. However,
32RA polyplexes exhibited a ﬂower-like morphology at charge ratio
10.0. Both the AFM results and the EtBr assay demonstrate weaker
condensation ability of the 32RA peptide relative to the other peptides.
This can be attributed to the spacing of the positive charges in this pep-
tide, as compared to the presence of continuous or clustered arginine
residues in the homopeptides and the motif containing peptides
respectively.
We next studied the DNA delivery efﬁciency of the motif-
containing peptides using luciferase reporter gene expression in
CHO-K1 cells. We assessed the transfection efﬁciency of all the pep-
tides at three different charge ratios 3.0, 5.0 and 10.0 (Fig. S1 in sup-
plemental data), and found that the maximum transfection efﬁciency
was obtained at charge ratio 10.0 for most of the peptides. As shown
in Fig. 3A, all arginine peptides were able to transfect DNA into the
cells. While 32A-R containing 16 arginine residues showed slightly
higher transfection efﬁciency than R16, 30A-R with 15 residues gave
slightly lower transfection than R16. The mild differences could be
due to the differences in the packaging of DNA. The 24A-R peptide,
with lower number of positive charges (12 arginine residues),
showed an order of magnitude lower transfection efﬁciency but the
values were comparable to that of R12 from our previous study [22].
On the other hand, the lysine-rich peptides demonstrated lower
transfection efﬁciencies although the values were comparable to or
slightly higher than that of K16 (Fig. 3B). This effect can be ascribed
to the different DNA compaction and release mechanisms adopted
by the lysine and arginine peptides as described earlier [22]. The
motif- containing peptides also showed similar packaging mecha-
nisms as the homopeptides. The lysine-rich peptides showedmultiple
modes of DNA compaction (both monomolecular and multimolecular
pathways) resulting in heterogeneous population at higher charge
Fig. 2.Morphology of DNA complexes formed by arginine and lysine based peptides show distinct differences. (A) Polyplexes of the different peptides were prepared at charge ratio
10.0. 3 μl of each of the polyplex was deposited onmica, air dried and imaged in air with an atomic force microscope. Arginine and lysine based peptides show distinct differences in
the populations of the polyplexes, whereas 32RA polyplexes show ﬂower-like morphology indicating incomplete condensation. (B) Polyplexes of 32A-R and 32A-K were made at
different charge ratios as indicated and imaged as above. At lower charge ratios (0.5 – 1.5), 32A-R shows multimolecular condensation involving two or more DNA molecules
whereas 32A-K condenses either single or multiple DNA molecules. Each image has dimension of 4x4 microns.
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pathway for DNA compaction leading to uniformly sized polyplexes
(Fig. 2B).
Since the overall transfection efﬁciencies were higher in case of the
peptide-DNA complexesmade from the different arginine-rich peptides,Fig. 3. Different motif containing peptides show varied efﬁciencies of DNA delivery.
CHO-K1 cells were treated with the polyplexes, at Z(+/−) 10.0, for 5 h at 37 °C. Trans-
fection efﬁciency was measured from luciferase gene expression after 24 h. Values are
given as mean±S.D. (A) Comparison of arginine based peptides with R16 homopeptide
(B) Comparison of lysine based peptides with K16 homopeptide.we restricted all further studies on the role of cell surface and exogenous
GAGs to the arginine containing peptides only.
3.2. Uptake of arginine-rich peptide-DNA complexes is independent of
cell surface GAGs
In our previous work, we had established that the arginine
homopeptide R16 can efﬁciently deliver DNA independent of the cell
surface GAGs [16]. To examine whether the modiﬁed arginine-rich
polyplexes were also able to show cellular entry in the absence of cell
surface GAGs, we studied the uptake of the polyplexes using ﬂow cy-
tometry (with FITC labeled DNA) in cell lines with varying GAG content
on the cell surface: i.e., wild type CHO-K1 and its GAG-deﬁcient mutant
pgsA-745. As shown in Fig. 4 (and S2), polyplexes of all the arginine-
rich peptides showed nearly 90% or more positive cells in both the cell
lines (except 32 RA at the lowest charge ratio), but a concentration de-
pendent increase in the respective mean ﬂuorescence intensities was
exhibited at increasing charge ratios for all the polyplexes. Yet, at each
charge ratio, no major difference was observed in the wild type and
the GAG-deﬁcient cell lines for any of the polyplexes. This is similar to
the uptake seen in these two cell lines for R16 polyplexes in our previous
work [16]. This indicates that the presence of arginine is sufﬁcient to
drive a GAG-independent entrymechanism and the distribution of pos-
itive charges, presence or absence of a GAG binding motif or even the
packaging of the peptide-DNA complexmay not play a role in determin-
ing this pathway.
3.3. Plasmid DNA delivery by arginine-rich peptides does not require cell
surface GAGs
Subsequent to the uptake studies in the wild type and GAG-
deﬁcient cell lines, we studied the transfection efﬁciencies of the
arginine-rich peptides in these two cell lines to check whether the
uptake pathway has any effect on the ultimate step of gene expression.
As shown in Fig. 5A (and S3), transfection efﬁciencies of all the
Fig. 4. Cellular uptake of arginine based polyplexes in wild-type and GAG-deﬁcient CHO cells are comparable. Complexes of arginine based peptides and FITC-labeled plasmid DNA,
prepared at increasing charge ratios 3.0, 5.0 and 10.0 (depicted by grey triangle on X-axis), were added to CHO-K1 and pgsA-745 cells. After 4 h of incubation at 37 °C, cells were washed
with ice-cold PBS containing 1 mg/ml heparin andwith 0.4% trypan blue in PBS. Cellswere collected by trypsinization and analyzedbyﬂowcytometry. Upper graph represents percentage
of ﬂuorescence positive cells of each sample and lower graph represents the respective mean ﬂuorescence intensity in arbitrary units. Values are given as mean±S.D.
Fig. 5. Transfection efﬁciency of arginine based polyplexes is not hugely altered in GAG-deﬁcient conditions. (A, B) Wild-type CHO-K1, its glycan-deﬁcient mutant pgsA-745 (A) and
HS-deﬁcientmutant pgsD-677 (B) were treatedwith arginine based polyplexes at Z(+/−) 10.0. Transfection efﬁciencywasmeasured from luciferase activity at 24 h after 5 h incubation
of the cells with the polyplexes. (C, D) CHO-K1 cells were pretreatedwith either chondroitinase ABC (250milliunits) (C) or heparinase III (2mIU) (D) for 1 h at 37 °C before transfection
was carried out.
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(at charge ratio 10.0) remained largely unaltered in the wild type
CHO-K1 and the GAG-deﬁcient pgsA-745 cell lines as seen in case of
R16. Even at lower charge ratios, major differences were not
observed in the transfection efﬁciencies of most of these peptides
(Fig. S1). Thus, all the arginine-rich polyplexes seem to adopt a GAG-
independent pathway. To further validate the role of cell surface
GAGs, transfection by the arginine-rich peptides were carried out
in the wild type CHO-K1 cells after enzymatic treatment with
chondroitinase ABC or heparinase III. There was a mild increase of not
more than 1.5 times in the transfection efﬁciency of the arginine-rich
peptides in the absence of either chondroitin sulfate (CS) or heparan
sulfate (HS) on the cell surface (Fig. 5C, D and S3). This further conﬁrms
that the normal levels of GAGs on the cell surface do not exhibit any
strong inhibitory effect on the transfection mediated by the different
sets of arginine-rich peptides.
We next checked the transfection efﬁciency of these peptides in a
third cell line pgsD-677 which does not produce HS but has a large
excess of CS on the cell surface. Here, while R16 exhibited similar
transfection efﬁciency as in the parent CHO-K1 and GAG-deﬁcient
pgsA-745, the motif- containing peptides as well as the 32RA peptide
showed reduced transfection by up to 3 times (Fig. 5B and S2). This
could be due to destabilization of selected polyplexes with clustered
or interspersed arginines by the higher amount of chondroitin sulfate
on the cell surface.
3.4. Arginine-rich peptides show enhanced transfection efﬁciency in
presence of exogenous GAGs
We have previously shown that addition of small amounts of exog-
enous GAGs to arginine homopeptides causes several fold increase in
their transfection efﬁciency [16]. To test the effect of exogenous GAGs
on the modiﬁed arginine peptides, different concentrations of HS and
chondroitin-6-sulphate (C6S) were added to the polyplexes at charge
ratio 10.0, and their transfection efﬁciency was determined in both
CHO-K1 and pgsA-745 cell lines. In CHO-K1, all the peptides containingFig. 6. Arginine based peptides show marginal increase in transfection efﬁciency in presen
(expressed as GAG:peptide w/w ratio) were added to the polyplexes at Z(+/−) 10.0. CHO
the polyplexes for 5 h at 37 °C, and luciferase gene expression was measured after 24 h. Vaheparin binding motifs showed a mild increase in transfection up to
nearly 1.5 X in presence of 1 μg of HS or 5 μg of C6S (which corresponds
to a GAG: peptide w/w ratio of 0.08:1 and 0.4:1 respectively), as shown
in Fig. 6A and B, followed by a decrease at higher amounts of either HS
or C6S. In the GAG-deﬁcient pgsA-745 cell line, 32A-R polyplexes
showed an increase in transfection of 2X with both HS and C6S,
although at different concentration (0.4:1 and 0.08:1 respectively) as
shown in Fig. 6C and D. Similar results were also obtained for the
30A-R peptide as given in supplementary ﬁg. S4. However, when the
length of the motif was decreased, i.e. in case of the 24A-R peptide, a
slight increase in transfection was seen only on the addition of C6S in
CHO-K1. On the other hand, the 32RA peptide did not show an increase
in transfection efﬁciency in CHO-K1 under any of the concentrations of
GAGs tested (Fig. 6A and B). But in the mutant pgsA-745, both HS and
C6S at lower concentrations caused an increase of 1.5 – 2 X in its trans-
fection efﬁciency (Fig. 6C and D). It seems that in case of the 32RA pep-
tide with different distribution of arginines and with weaker DNA
condensation ability, the additional presence of cell surface GAGs in
CHO-K1 poses a barrier leading to reduced transfection in this cell line
in presence of exogenous GAGs unlike in the GAG-deﬁcient pgsA-745.
3.5. Arginine rich peptide-DNA complexes are stable when exposed to
soluble GAGs
Although the arginine-rich peptides showed an increase in trans-
fection efﬁciency in presence of exogenous GAGs under most of the
conditions tested above, the increase was mild when compared to
that seen with arginine homopeptide R16. In case of R16, up to 20X in-
crease in transfection was observed with exogenous HS and CS [16]
whereas the increase was barely up to 2 fold in case of selected
motif- containing peptides. Moreover, for the shorter length of the
motif-containing peptide, there was no increase in transfection efﬁ-
ciency under certain concentrations of the HS and CS used. In order
to understand this difference between the homopeptide and the
motif containing arginine-rich peptides, we sought to determine the
inherent stability of these polyplexes when exposed to increasingce of exogenous glycosaminoglycans. Increasing amounts of HS (A, C) and C6S (B, D)
-K1 (dark grey bars A, B) and pgsA-745 (light grey bars C, D) cells were treated with
lues are given as mean±S.D.
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electrophoresis and EtBr intercalation assay. As shown in Fig. 7A,
polyplexes made with the motif containing peptides were destabilized
on anionic challenge with heparin. Even at a low GAG:peptide w/w of
0.8:1, heparin, which has the highest negative charge density amongst
GAGs, could achieve complete release of the compacted DNA. On the
other hand, these polyplexes were quite stable against the less nega-
tively charged CS, with only slight destabilization occurring at very
high GAG:peptide w/w of 800:1. HS, with higher negative charge densi-
ty than CS, showed destabilization of the polyplexes atw/w ratios of 8:1
and higher. The 32RA polyplexesweremore easily perturbed by soluble
GAGs than the motif containing peptides, as seen by release of the
compacted DNA at lower GAG:peptide w/w ratios.
The EtBr intercalation assay is a more sensitivemethod to assess the
destabilization of polyplexes due to soluble GAGs, since it can deter-
mine even partially loosened DNAwhich is unable tomigrate in an aga-
rose gel. In this assay, the destabilization of polyplexes on anionic
challenge causes EtBr to intercalate into the DNA resulting in ﬂuores-
cence recovery. Heparin caused nearly 60% ﬂuorescence recovery for
all the polyplexes at GAG:peptide w/w ratio of 0.8:1 (Fig. 7B), while at
a similar w/w ratio, R16 polyplexes showed only 30% recovery [16].
Polyplexes showed ﬂuorescence recovery up to nearly 80% when chal-
lenged with HS at higher GAG:peptide w/w ratios, whereas with C6S,
the recovery remained more or less static at about 50% from w/w
ratio of 0.8:1. At the GAG:peptidew/w ratios where enhanced transfec-
tionwas seen formotif-containing peptides (0.08:1 and 0.4:1), theﬂuo-
rescence recovery was found to be higher than that observed for R16
polyplexes [16]. The 32RA polyplexes showed destabilization at lower
w/w ratios of GAG:peptide, indicating that they are less stable as com-
pared to the motif containing peptides. Therefore, the homopeptide
with the continuous stretch of positive charges formed inherently
more stable complexes than those formed by the peptides with clus-
tered or interspersed arrangement of arginines. This could be dictating
the rather small or even no enhancement (in selected cases) in transfec-
tion efﬁciency in presence of exogenous GAGs for the different arginine-
rich peptides.Fig. 7. Arginine based polyplexes are resistant to anionic challenge by low amounts of GAG
(Heparin, HS and C6S) expressed as GAG:peptide w/w ratios. Stability was checked as a mea
was compared to free plasmid DNA in lane 1 (B) Ethidium bromide intercalation assay. Am
EtBr. Fluorescence of free plasmid complexed to EtBr is taken as 100%. Values are plotted a3.6. Exogenous GAGs do not alter the morphology of arginine peptide-DNA
complexes, but protect them from nuclease
From the results described above, it was clear that although the
polyplexes containing the motif peptides showed destabilization at
high amounts of added GAGs, they were resistant to destabilization
in presence of low amounts of soluble GAGs. Therefore, in the latter
case, the morphology of the 32A-R polyplexes in presence of GAGs
was studied using Atomic Force Microscopy (Fig. 8A). The complexes
at charge ratio of 10.0 did not exhibit any difference in their size or
morphology in presence of HS or CS at w/w ratio of 0.08:1. At higher
ratio of 0.4:1, the complexes had increased sizes, probably due to the
attachment of GAGs on its surface, but destabilization in the form of
DNA strands was not observed up to w/w ratio of 0.8:1. Free DNA
was observed in the presence of HS at a high w/w ratio of 8:1 indicat-
ing destabilization of the polyplexes.
The sizes of the polyplexes on addition of CS at w/w ratio of 0.4:1
were also determined by dynamic light scattering. As given in Fig. 8B,
the addition of GAG caused an increase of 20–30 nm in the polyplexes
of motif-containing peptides, corroborating the AFM studies. But, the
size of the 32RA polyplex increased by only 10 nm, indicating that
these polyplexes are not able to accommodate GAGs efﬁciently on
their surface.
Consequently, we wanted to check whether the ternary com-
plexes of polyplexes with GAGs could protect the compacted DNA
from nucleases as efﬁciently as the free polyplexes. This was done
using a DNase I protection assay and the results are shown in
Fig. 8C. In the case of the 32A-R polyplex with HS or CS (at GAG:pep-
tide w/w of 0.4:1), the compacted DNA was effectively protected up
to a level similar to or higher than the native peptide-DNA complex.
However, this effect was not observed for the 24A-R complex, possi-
bly due to lower number of arginine residues and weaker interaction
with GAGs. As for the 32RA polyplex, protection against DNase I was
not seen at any of the concentrations or type of GAG used, which
could be attributed to the destabilization of the polyplex at even
low amounts of GAGs, making the DNA susceptible to nuclease attack.s. Polyplexes at Z(+/−) 10.0 were treated with increasing amounts of different GAGs
sure of the DNA released by: (A) Agarose gel electrophoresis. Amount of DNA released
ount of DNA released was measured by increase in the ﬂuorescence by intercalation of
s percentage of maximum±S.D.
Fig. 8. DNA protection ability of arginine based polyplexes improves when treated with exogenous GAGs. (A) 32A-R polyplexes were treated with increasing amounts of HS and C6S
expressed as GAG:peptide w/w ratio. 3 μl of the resulting complex was deposited onmica, air dried and imaged in air with an atomic force microscope. Each image has dimension of
4x4 microns. (B) Average hydrodynamic diameter and polydispersity index (PDI) of polyplexes at Z(+/−) 10.0, with and without exogenous C6S (at w/w ratio of 0.4:1) determined
by dynamic light scattering. (C) Polyplexes at Z(+/−) 10.0, were treated with GAGs (HS, CSA and C6S) at 0.4:1 and 0.8:1 GAG:peptide w/w. Complexes were then subjected to
DNase 1 (1U) treatment. The amount of DNA protected was then released by heparin and checked by agarose gel electrophoresis. Controls: lane C1-free plasmid; lane
C2-polyplex treated with heparin; lane C3-polyplex treated with DNaseI and heparin.
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Basic residues like arginine and lysine are widely used in peptide-
based DNA delivery systems because they can efﬁciently condense a
large negatively charged plasmid DNA molecule into a small compact
nanoparticle that is able to traverse the plasma membrane and deliver
functional DNA inside the cells. Moreover, arginine based peptides are
known to possess cell penetrating properties, making them attractive
carriers for a wide variety of cargos [14,15]. The mechanism of cellular
entry of arginine-rich peptides, either free or with a cargo, is still debat-
able since both membrane translocation and endocytosis seem to be
operative at different conditions and the involvement of cell surface
GAGs in this process also seems to be variable [8,9,12]. In our earlier
work, we have demonstrated that cell surface GAGs are dispensable
for the entry of arginine homopeptide R16 and its complex with DNA,
as seen by comparable uptake and transfection in glycan-deﬁcient con-
ditions [16]. Additionally, arginine polyplexes could interact with small
amounts of soluble GAGs, resulting in increased polyplex stability,better uptake and enhanced transfection efﬁciency. In contrast, com-
plexes with lysine peptide K16 adopted a primarily GAG-dependent
pathway for cellular entry and were destabilized with even small
amounts of exogenously added GAGs. We had rationalized that the
distinctive peptide chemistry leading to consequent differences in
polyplex stability and condensation-release balance is one of the
major factors responsible for this difference.
In light of the above observations, we wanted to check whether
modiﬁcations in the sequences and charge distribution of the arginine
peptides cause any change in their interactionwith cell surface and sol-
uble GAGs as compared to the arginine homopeptides. Towards this
goal, we chose arginine-rich peptides of different lengths (and varying
number of positive charges) containing a heparin-binding motif as
listed in Table 1. Additionally, the arginines are clustered in these pep-
tides as compared to the contiguous distribution in homopeptides. For
comparison, we also chose another peptide, 32RA, which contains argi-
nines interspersed throughout the peptide and without a heparin-
binding motif. We also compared the results with the corresponding
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peptides used in this study, we observed that the arginine based pep-
tides showed better DNA condensation ability in most of the cases and
subsequently higher transfection efﬁciency than their lysine counter-
parts (Figs. 1–3). Similar to the results obtained for homopeptides [22],
the mechanism of DNA condensation by the motif containing arginine
and lysine based 32-mer peptides was different (Fig. 2B), resulting in a
homogenous population of nearly spherical particles for the arginine
polyplexes at charge ratio of 10.0, whereas the lysine polyplexes showed
a heterogeneous population consisting of both spherical and rod-shaped
particles at the same charge ratio.
Consequentially, the next question thatwe addressed iswhether the
presence of the motif would stimulate these polyplexes to gain cellular
entry by a GAG-dependent pathway. To answer this, we chose arginine
based peptides containing the motif, not only due to their higher trans-
fection efﬁciency, but also because similar arginine-rich peptides with
the motif have been shown to have higher afﬁnity for GAGs than
those peptides with majority of lysines [19,21]. We checked for the cel-
lular uptake as well as the transfection efﬁciency of these polyplexes in
the wild-type CHO-K1 cell line and its GAG-deﬁcient mutant pgsA-745
cell line that producesminimal amounts of cell surfaceGAGs (b10%, [3])
and also under conditions where the GAGs have been selectively re-
moved from the cell surface. As seen from Figs. 4 and 5, the polyplexes
of all the arginine-richmotif-containing peptides, irrespective of the se-
quence or length ofmotif, were able to enter cells andmediate transfec-
tion in the presence as well as absence of cell surface GAGs, thereby
ruling out a GAG-dependent entry mechanism. Although a decrease in
transfection efﬁciency of the motif containing peptides and the 32RA
peptide was seen in pgsD-677 (HS-deﬁcient cell line) (Fig. 5B) but not
for the homopeptide, it could be assumed that destabilization of the
polyplexes in presence of the excess chondroitin sulfate on the cell sur-
face occurs through a charge-charge interaction and not due to speciﬁc
binding to GAGs. Our results show that arginine-rich peptides show
GAG-independent mechanism for cellular uptake in spite of the pres-
ence of a heparin binding motif that can interact with the cell surface
GAGs. Although it has been established that clusters of arginine residues
that are spaced out with non-basic residues enhances interaction with
heparan sulfate in vitro [23], it is possible that these peptides, when
complexed with DNA, do not adopt the structural orientation required
for optimum interaction with GAGs such as the α-helix or the
β-sheet. Under this condition, only the presence of arginine residues
in the peptides may be responsible for mediating the cellular entry. It
is also known that arginine peptides can interact withmembrane phos-
pholipids through bidentate hydrogen bonding between the guanidium
side chain in arginine and the phosphate groups in phospholipids [24].
Therefore, the membrane phospholipids may be alternate interaction
partners for the arginine-rich peptides.
Even though GAGs are not required for the cellular entry of any of
the arginine-rich peptides used in this study, it was observed that the
arrangement of the arginine residues in the peptides contributed to dif-
ferences in the relative stability of the polyplexes formed, and ultimate-
ly the levels of transfection efﬁciency. 32A-R polyplexes showed more
destabilization than R16 polyplexes in presence of the same concentra-
tion of anionic agent although both sequences contain 16 arginines
(Fig. 7B and [16]). This maymake the 32A-R polyplexesmore accessible
to the transcription machinery inside a cell through easier release of
DNA and could be responsible for nearly 2X higher transfection than
R16 (Fig. 3). However, weakDNA condensation by the peptide and high-
ly facile destabilization of the polyplexes it forms can lower the trans-
fection efﬁciency. For example, the transfection efﬁciency of 32RA was
found to be lower than that of the 32A-R (~ 4.5X lower) as well as the
R16 peptides (~ 2.5X lower) (Fig. 5A), possibly due to itsweaker conden-
sation of DNA (as seen from Fig. 1), greater susceptibility to even low
amounts of anionic challenge (Fig. 7B) and premature degradation by
nucleases (Fig. 8C). When the 32A-R and 24A-R polyplexes with the
same motif sequence but different number of arrays were compared,the transfection efﬁciency of 24A-R (containing 12 arginines) was
found to be much lower than that of 32A-R, but comparable to R12
from previous studies [22]. Therefore, as shown previously [22,25], in-
creasing the number of positive charges leads to increased transfection
efﬁciency.
We also explored the effect of presence of the heparin-binding
motif in the interaction with exogenous GAGs, since arginine
homopeptide R16 was shown to exhibit enhanced transfection efﬁ-
ciency in presence of low amounts of exogenous GAGs [16]. If the
motif-containing peptides with the clustered arginines could indeed
interact with the soluble GAGs without causing destabilization of
the polyplexes, we expect a concomitant increase in the transfection
efﬁciency. However, the increase in transfection was unexpectedly
mild (up to 2X) for most of the polyplexes at concentration ranges
of GAG:peptide w/w of 0.08: 1 to 0.4:1, followed by a decrease at
higher GAG amounts (Fig. 6). This phenomenon can again be
explained by the relative stability of the polyplexes in comparison
to R16, as discussed earlier. Even in the case of the 32RA peptide
with interspersed arginines, an increase in transfection with low
amounts of soluble GAGs was seen in the pgsA-745 cell line, but not
in the CHO-K1 cells where the cell surface GAGs may destabilize the
polyplexes. Thus, stability of the peptide-DNA complexes containing
different arrangements of arginine residues, in the presence of exog-
enous GAGs, may be ordered as interspersedbclusteredbcontiguous.
The addition of low amounts of exogenous GAGs leads to an increase
in the size of the motif-containing polyplexes by 20–30 nm (Fig. 8A
and B). It can be assumed that at the low amounts of GAGs, a ternary
complex is formed between the polyplexes and GAGs, which stabi-
lizes the polyplexes. The resulting complexes show increased protec-
tion from nucleases (Fig. 8C), leading to improved cellular uptake and
transfection efﬁciency. The effect was seen with both HS and CS,
thereby ruling out any GAG speciﬁcity in this process.
In summary, we have demonstrated that the presence of a
heparin-binding motif does not offer any advantage to peptides to
gain cellular entry through cell surface GAGs, but rather the presence
of arginines by itself drives these peptides to a GAG-independent
entry mechanism. Arrangement of arginine residues in the form of
clusters of positive charge separated by non-basic residues helps to
improve the transfection efﬁciency. However, in order to enhance
transfection efﬁciency of arginine-rich peptides by physical coating
of low amounts of soluble GAGs, it is necessary to have contiguous
stretch of arginine residues. This improves the stability of the com-
plexes as well as maximizes the interaction with soluble GAGs as
compared to clustered blocks of positive charges. Therefore, a balance
between spacing of positive charges and the number of charges in
each block would help in designing more efﬁcient arginine-based
peptide systems for DNA delivery.
Acknowledgements
This work was supported by Council of Scientiﬁc and Industrial Re-
search (CSIR), Govt. of India (Project NWP35). Fellowship from Depart-
ment of Biotechnology (DBT), Govt. of India to RJN is acknowledged.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamem.2013.02.010.
References
[1] M. Belting, Heparan sulfate proteoglycan as a plasma membrane carrier, Trends
Biochem. Sci. 28 (2003) 145–151.
[2] G.M. Poon, J. Garie´py, Cell surface proteoglycans as molecular portals for cationic
peptide and polymer entry into cells, Biochem. Soc. Trans. 35 (2007) 788–793.
[3] M. Ruponen, P. Honkakoski, M. Tammi, A. Urtti, Cell-surface glycosaminoglycans
inhibit cation-mediated gene transfer, J. Gene Med. 6 (2004) 405–414.
1493R.J. Naik et al. / Biochimica et Biophysica Acta 1828 (2013) 1484–1493[4] M. Tyagi, M. Rusnati, M. Presta, M. Giacca, Internalization of HIV-1 Tat re-
quires cell surface heparan sulfate proteoglycans, J. Biol. Chem. 276 (2001)
3254–3261.
[5] J.P. Richard, K. Melikov, H. Brooks, P. Prevot, B. Lebleu, L.V. Chernomordik, Cellular
uptake of unconjugated TAT peptide involves clathrin dependent endocytosis and
heparan sulfate receptors, J. Biol. Chem. 280 (2005) 15300–15306.
[6] S.M. Fuchs, R.T. Raines, Pathway for polyarginine entry into mammalian cells,
Biochemistry 43 (2004) 2438–2444.
[7] I. Nakase, A. Tadokoro, N. Kawabata, T. Takeuchi, H. Katoh, K. Hiramoto, M.
Negishi, M. Nomizu, Y. Sugiura, S. Futaki, Interaction of arginine-rich peptides
with membrane-associated proteoglycans is crucial for induction of actin organi-
zation and macropinocytosis, Biochemistry 46 (2007) 492–501.
[8] S. Futaki, I. Nakase, A. Tadokoro, T. Takeuchi, A.T. Jones, Arginine-rich peptides
and their internalization mechanisms, Biochem. Soc. Trans. 35 (2007) 784–787.
[9] C. Jiao, D. Delaroche, F. Burlina, I.D. Alves, G. Chassaing, S. Sagan, Translocation
and endocytosis for cell-penetrating peptide internalization, J. Biol. Chem. 284
(2009) 33957–33965.
[10] S. Console, C. Marty, C. García-Echeverría, R. Schwendener, K. Ballmer-Hofer,
Antennapedia and HIV Transactivator of Transcription (TAT) “Protein Tranduction
Domains” promote endocytosis of high molecular weight cargo upon binding to
cell surface glycosaminoglycans, J. Biol. Chem. 278 (2003) 35109–35114.
[11] S. Sandgren, F. Cheng,M. Belting,Nuclear targeting ofmacromolecular polyanionsby
an HIV-Tat derived peptide, J. Biol. Chem. 277 (2002) 38877–38883.
[12] J.M. Gump, R.K. June, S.F. Dowdy, Revised role of glycosaminoglycans in TAT protein
transduction domain-mediated cellular transduction, J. Biol. Chem. 285 (2010)
1500–1507.
[13] S.R. Schwarze, K.A. Hruska, S.F. Dowdy, Protein transduction: unrestricted delivery
into all cells? Trends Cell Biol. 10 (2000) 290–295.
[14] M. Mae, U. Langel, Cell-penetrating peptides as vectors for peptide, protein and
oligonucleotide delivery, Curr. Opin. Pharmacol. 6 (2006) 509–514.
[15] I. Nakase, H. Akita, K. Kogure, A. Graslund, U. Langel, H. Harashima, S. Futaki, Efﬁcient
intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating
peptides, Acc. Chem. Res. 45 (2012) 1132–1139.[16] R.J. Naik, P. Chandra, A. Mann, M. Ganguli, Exogenous and cell surface glycosami-
noglycans alter DNA delivery efﬁciency of arginine and lysine homopeptides in
distinctly different ways, J. Biol. Chem. 286 (2011) 18982–18993.
[17] M. Kosuge, T. Takeuchi, I. Nakase, A.T. Jones, S. Futaki, Cellular internalization and
distribution of arginine-rich peptides as a function of extracellular peptide con-
centration, serum and plasma membrane associated proteoglycans, Bioconjugate
Chem. 19 (2008) 656–664.
[18] A. Subrizi, E. Tuominen, A. Bunker, T. Rog, M. Antopolsky, A. Urtti, Tat(48–60)
peptide amino acid sequence is not unique in its cell penetrating properties and
cell-surface glycosaminoglycans inhibit its cellular uptake, J. Controlled Release
158 (2012) 277–285.
[19] J.R. Fromm, R.E. Hileman, E.E.O. Caldwell, J.M. Weiler, R.J. Linhardt, Differences in
the interaction of heparin with arginine and lysine and the importance of these
basic amino acids in the binding of heparin to acidic ﬁbroblast growth factor,
Arch. Biochem. Biophys. 323 (1995) 279–287.
[20] A.D. Cardin, H.J.R. Weintraub, Molecular modeling of protein-glycosaminoglycan
interactions, Arteriosclerosis 9 (1989) 21–32.
[21] A. Verrecchio, M.W. Germann, B.P. Schick, B. Kung, T. Twardowski, J.D.S. Antonio,
Design of peptides with high afﬁnities for heparin and endothelial cell proteogly-
cans, J. Biol. Chem. 275 (2000) 7701–7707.
[22] A. Mann, G. Thakur, V. Shukla, A.K. Singh, R. Khanduri, R. Naik, Y. Jiang, N. Kalra,
B.S. Dwarakanath, U. Langel, M. Ganguli, Differences in DNA condensation and
release by lysine and arginine homopeptides govern their DNA delivery efﬁciencies,
Mol. Pharmaceutics 8 (2011) 1729–1741.
[23] J.R. Fromm, R.E. Hileman, E.E.O. Caldwell, J.M. Weiler, R.J. Linhardt, Pattern and
spacing of basic amino acids in heparin binding sites, Arch. Biochem. Biophys.
343 (1997) 92–100.
[24] A.Walrant, C. Bechara, I.D. Alves, S. Sagan,Molecular partners for interaction and cell
internalization of cell-penetrating peptides: how identical are they? Nanomedicine
(London, U. K.) 7 (2012) 133–143.
[25] J.B. Rothbard, E. Kreider, C.L. VanDeusen, L. Wright, B.L. Wylie, P.A. Wender,
Arginine-rich molecular transporters for drug delivery: role of backbone spacing
in cellular uptake, J. Med. Chem. 45 (2002) 3612–3618.
